Related Experiment Videos

Mesothelioma of childhood

A E Fraire1, S Cooper, S D Greenberg

  • 1Department of Pathology, Baylor College of Medicine, Houston, TX 77030.

Cancer
|August 15, 1988
PubMed

Insights

Childhood malignant mesothelioma (MM) is a rare cancer. Diagnosis is challenging, but MM in children is a distinct entity with a poor prognosis, and evidence does not link it to asbestos, radiation, or isoniazid.

Area of Science:

  • Pediatric Oncology
  • Pathology
  • Epidemiology

Background:

  • Malignant mesothelioma (MM) in children is a rare but significant neoplasm.
  • Understanding its characteristics and diagnostic challenges is crucial for patient outcomes.

Purpose of the Study:

  • To review cases of childhood malignant mesothelioma.
  • To assess diagnostic accuracy and identify potential risk factors.
  • To evaluate the prognosis of pediatric MM.

Main Methods:

  • Retrospective review of 80 children with a previous MM diagnosis.
  • Independent and joint review of tissue slides by a panel of three pathologists for 22 cases.
  • Analysis of patient demographics, tumor characteristics, risk factors, and follow-up data.

Main Results:

  • Of 22 reviewed cases, 10 were confirmed as MM, 9 reclassified, and 3 deemed uncertain.
  • Six of the confirmed MM cases were in boys and four in girls.
  • Eight pleural and two peritoneal tumors were identified; prognosis was generally grave, with mortality in four patients within 48 months.
  • Limited evidence supported a causal link to asbestos, radiation, or in utero isoniazid exposure.

Conclusions:

  • Childhood malignant mesothelioma is a valid clinicopathological entity.
  • Accurate diagnosis is challenging and best achieved by a panel of expert pathologists.
  • The prognosis for pediatric MM is poor, and current evidence does not establish causal relationships with common risk factors.

Related Concept Videos